Subtransverse Interligamentary Block Versus Paravertebral Block for Quality of Recovery After Mas… (NCT07647367) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Subtransverse Interligamentary Block Versus Paravertebral Block for Quality of Recovery After Mastectomy
Egypt60 participantsStarted 2026-06
Plain-language summary
This prospective randomized controlled double blinded non-inferiority study will be carried out in Tanta University Hospitals for duration of 6 months from June 2026 to December 2026 on 60 female patients scheduled for unilatral modified radical mastectomy under general anesthesia.
Who can participate
Age range
18 Years – 65 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Adult female patients aged 18 to 65 years with American Society of Anesthesiologists (ASA) Physical Status I - III, who were scheduled for unilateral MRM surgery under general anesthesia and able to understand and complete the QoR-15 questionnaire
Exclusion Criteria:
* • Patients declined to participate in the trial.
* History of allergy to the used local anesthetic (LA) drugs.
* Patients with cutaneous lesions at the needle entry point.
* Coagulopathy or current anticoagulant therapy contraindicating regional block.
* Patients with severe hepatic, renal, cardiac, or respiratory disease.
* Psychiatric or cognitive disorder interfering with QoR-15 assessment
* Chronic opioid use or chronic pain syndrome.
* Failed block.
* Morbid obesity (body mass index \>40 kg/m2)
* Intraoperative major complications requiring postoperative ICU admission.
* Pregnancy
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Postoperative quality of recovery
Timeframe: It will be measured 24 hours after surgery